Mitchell C. Shultz, MD
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shultz, Karen
Ersa, NCT05454956: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

Completed
2
40
US
TP-03, TP-03 Vehicle
Tarsus Pharmaceuticals, Inc.
Meibomian Gland Dysfunction, Blepharitis, Demodex Infestation
05/23
05/23
Rhea, NCT06054217: Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex

Active, not recruiting
2
36
US
Vehicle of TP-03, Exploratory Vehicle
Tarsus Pharmaceuticals, Inc.
Meibomian Gland Dysfunction, Demodex Infestation of Eyelid, Blepharitis, Demodectic Blepharitis
06/24
06/24
Shultz, Mitchell
NCT05555589: Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Recruiting
3
70
US
RGN-259, Tβ4, Thymosin Beta 4, Timbetasin, Placebo, Vehicle Control
ReGenTree, LLC
Neurotrophic Keratopathy
07/24
11/24
NCT05456425: A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

Recruiting
3
600
US, RoW
CBT-001, Vehicle
Cloudbreak Therapeutics, LLC
Pterygium
12/25
12/26
Ersa, NCT05454956: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

Completed
2
40
US
TP-03, TP-03 Vehicle
Tarsus Pharmaceuticals, Inc.
Meibomian Gland Dysfunction, Blepharitis, Demodex Infestation
05/23
05/23
Rhea, NCT06054217: Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex

Active, not recruiting
2
36
US
Vehicle of TP-03, Exploratory Vehicle
Tarsus Pharmaceuticals, Inc.
Meibomian Gland Dysfunction, Demodex Infestation of Eyelid, Blepharitis, Demodectic Blepharitis
06/24
06/24

Download Options